Replimune

-$1.41 (-4.19%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3.

CEO
Philip Astley-Sparke
Employees
152
Headquarters
Woburn, Massachusetts
Founded
2015

REPL Key Statistics

Market Cap
1.51B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
243.85K
High Today
$33.25
Low Today
$32.21
Open Price
$33.19
Volume
191.39K
52 Week High
$54.85
52 Week Low
$20.40

REPL Earnings

-$1.75
-$1.17
-$0.58
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure